Scientific publications

Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer

Josefa Salgado [SP] (1), Natalia Zabalegui (4), Carmen Gil (1), Ignacio Monreal [SP] (2), Javier Rodríguez [SP] (3) and Jesús García-Foncillas (1,3)
Laboratories of (1) Biotechnology, (2) Biochemistry and (3) Department of Oncology, University Clinic of Navarra (CUN), Avda. Pio XII 36; 4Laboratory of Gene Therapy Application, Centre for Applied Medical Research (CIMA), Avda. Pio XII 55, 31008 Pamplona, Navarra, Spain

Magazine: Oncology Reports

Date: Feb 1, 2007

Medical Oncology Biochemistry [SP] Clinical Genetics Unit [SP] Digestive Tract Tumours Area

Pharmacogenetics is an increasingly useful field where the genetic studies are becoming an important tool for predicting drug toxicity and/or efficacy. Thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) gene polymorphisms could be highly informative tools in the clinical handling of colorectal cancer patients, who are following fluoropyrimidine based chemotherapy. Fifty-eight patients, with non-resectable metastatic colorectal cancer, were treated with capecitabine and raltitrexed, every three weeks.

Patients were divided in a good-response group (complete and partial response) and a poor-response group (stable and progression). A genotype panel TS-DPD was evaluated. Results show that TS genotype analysis clearly differentiates patients with a worst response to a 5-fluorouracil based chemotherapy. DPD genotype was shown to be highly informative for prediction of toxicity of the treatment.

These polymorphisms could represent an accurate, rapid and effective determination panel, indicative of resistance and toxicity for patients undergoing fluoropyrimidine based treatment.

CITATION  Oncol Rep. 2007 Feb;17(2):325-8

you maybe interested


The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra


The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra


Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra